Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1

被引:251
作者
Lebbink, Robert Jan
de Ruiter, Talitha
Adelmeijer, Jelle
Brenkman, Arjan B.
van Helvoort, Joop M.
Koch, Manuel
Farndale, Richard W.
Lisman, Ton
Sonnenberg, Arnoud
Lenting, Peter J.
Meyaard, Linde [1 ]
机构
[1] Univ Utrecht, Ctr Med, Dept Immunol, NL-3584 EA Utrecht, Netherlands
[2] Univ Utrecht, Ctr Med, Thrombosis & Haemostasis Lab, NL-3584 EA Utrecht, Netherlands
[3] Univ Utrecht, Ctr Med, Dept Physiol Chem, NL-3584 EA Utrecht, Netherlands
[4] Univ Cologne, Ctr Mol Med, Ctr Biochem, D-50931 Cologne, Germany
[5] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany
[6] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England
[7] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands
基金
英国医学研究理事会;
关键词
D O I
10.1084/jem.20052554
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Collagens are the most abundant proteins in the human body, important in maintenance of tissue structure and hemostasis. Here we report that collagens are high affinity ligands for the broadly expressed inhibitory leukocyte-associated immunoglobulin-like receptor-1 ( LAIR-1). The interaction is dependent on the conserved Gly-Pro-Hyp collagen repeats. Antibody crosslinking of LAIR-1 is known to inhibit immune cell function in vitro. We now show that collagens are functional ligands for LAIR-1 and directly inhibit immune cell activation in vitro. Thus far, all documented ligands for immune inhibitory receptors are membrane molecules, implying a regulatory role in cell-cell interaction. Our data reveal a novel mechanism of peripheral immune regulation by inhibitory immune receptors binding to extracellular matrix collagens.
引用
收藏
页码:1419 / 1425
页数:7
相关论文
共 31 条
[1]   Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells [J].
Banyard, J ;
Bao, L ;
Zetter, BR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) :20989-20994
[2]  
de Vries ARV, 1999, EUR J IMMUNOL, V29, P3160
[3]   The role of collagen in thrombosis and hemostasis [J].
Farndale, RW ;
Sixma, JJ ;
Barnes, MJ ;
De Groot, PG .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) :561-573
[4]   Collagenous transmembrane proteins: Recent insights into biology and pathology [J].
Franzke, CW ;
Bruckner, P ;
Bruckner-Tuderman, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (06) :4005-4008
[5]   Collagens -: structure, function, and biosynthesis [J].
Gelse, K ;
Pöschl, E ;
Aigner, T .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (12) :1531-1546
[6]  
GIOUD M, 1982, COLLAGEN REL RES, V2, P557
[7]   Overexpression of collagen XVIII is associated with poor outcome and elevated levels of circulating serum endostatin in non-small cell lung cancer [J].
Iizasa, T ;
Chang, H ;
Suzuki, M ;
Otsuji, M ;
Yokoi, S ;
Chiyo, M ;
Motohashi, S ;
Yasufuku, K ;
Sekine, Y ;
Iyoda, A ;
Shibuya, K ;
Hiroshima, K ;
Fujisawa, T .
CLINICAL CANCER RESEARCH, 2004, 10 (16) :5361-5366
[8]   Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen [J].
Knight, CG ;
Morton, LF ;
Onley, DJ ;
Peachey, AR ;
Ichinohe, T ;
Okuma, M ;
Farndale, RW ;
Barnes, MJ .
CARDIOVASCULAR RESEARCH, 1999, 41 (02) :450-457
[9]   NK cell recognition [J].
Lanier, LL .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :225-274
[10]   Identification and characterization of the rat homologue of LAIR-1 [J].
Lebbink, RJ ;
de Ruiter, T ;
Kaptijn, GJA ;
Meyaard, L .
IMMUNOGENETICS, 2005, 57 (05) :344-351